Analyze the Cardiovascular Benefits of the Different GLP-1 Agonists

Dulaglutide (Trulicity) will be the third GLP-1 agonist to show CV benefits in some patients with type 2 diabetes....

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals